We performed the same analysis for TUG1 on four cancer cell lines (osteosarcoma U-2 OS, cervical cancer HeLa, colorectal cancer HCT116, and glioblastoma LN-18) and two non-tumor-derived cell types (embryonic kidney HEK293T and BJ fibroblasts); and for TERT on 4 cell lines with TERT re-activation (HeLa, HCT116, HEK293T, and LN-18). This evidence concerns the gene TUG1 and osteosarcoma.